Efficacy and safety of bivalirudin during percutaneous coronary intervention in high‐bleeding‐risk elderly patients with chronic total occlusion: A prospective randomized controlled trial
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28087
Abstract: To assess the efficacy and safety of bivalirudin during percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) in high‐bleeding‐risk elderly patients. read more here.
Keywords: efficacy safety; bivalirudin percutaneous; percutaneous coronary; coronary intervention ... See more keywords
Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?
Sign Up to like & getrecommendations! Published in 2017 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2017.10.23
Abstract: Percutaneous coronary intervention (PCI) is the cornerstone of management for patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) (1-6). Anticoagulation is routinely administered during PCI in order to minimize the risk of… read more here.
Keywords: heparin versus; versus bivalirudin; bivalirudin percutaneous; percutaneous coronary ... See more keywords